Thymidylate synthetase pseudogene 2 (TYMSP2)

Thymidylate synthetase pseudogene 2 (TYMSP2) is classified as a pseudogene, meaning it is a non-functional copy of the protein-coding gene for thymidylate synthase (TYMS)[1]. Pseudogenes like TYMSP2 do not code for functional proteins and generally have no direct biological or therapeutic role. While the functional TYMS is a critical enzyme targeted in cancer therapy due to its essential role in DNA synthesis and repair[2][3][5], TYMSP2 encodes a non-functional, aberrantly processed RNA with no reported protein product or drug interactions[1]. There is currently no evidence linking TYMSP2 to disease, clinical biomarkers, or therapy response. Assessment of correctness: - The gene "thymidylate synthetase pseudogene 2" (TYMSP2) is a pseudogene and not a therapeutic target or receptor. - There is likely confusion or overinterpretation in considering it as a target; the functional gene of interest for therapy is "Thymidylate synthase" (TYMS), not its pseudogene TYMSP2[2][3][5]. - No functional protein, drug interaction, or mechanistic action is associated with TYMSP2 based on available data. If you intended to refer to the canonical enzyme "thymidylate synthase" (TYMS), that is a known anticancer drug target[2][3][5]. However, TYMSP2 is a pseudogene and is not used as a molecular target.

Other names

TYMSP2